دورية أكاديمية

SIRT1 (rs3740051) role in pituitary adenoma development

التفاصيل البيبلوغرافية
العنوان: SIRT1 (rs3740051) role in pituitary adenoma development
المؤلفون: Rasa Liutkeviciene, Alvita Vilkeviciute, Greta Morkunaite, Brigita Glebauskiene, Loresa Kriauciuniene
المصدر: BMC Medical Genetics, Vol 20, Iss 1, Pp 1-7 (2019)
بيانات النشر: BMC, 2019.
سنة النشر: 2019
المجموعة: LCC:Internal medicine
LCC:Genetics
مصطلحات موضوعية: Pituitary adenoma, SIRT1 (rs4746720, rs3740051) gene polymorphisms, Invasiveness, Internal medicine, RC31-1245, Genetics, QH426-470
الوصف: Abstract Background Our purpose was to determine if SIRT1 (rs4746720, rs3740051) genotypes have an influence on the development of pituitary adenoma (PA). Methods The study group included 142 patients with pituitary adenoma (PA) and the control group consisted of 826 healthy people. The genotyping of SIRT1 (rs4746720, rs3740051) was carried out using the real-time polymerase chain reaction method. Results Statistically significant results were obtained in the analysis of SIRT1 rs3740051. Significant differences in genotype (G/G, G/A, A/A) distribution were obtained comparing patients with PA without recurrence and PA with recurrence (0, 17.9, 82.1% vs. 6.7, 6.7, 86.7%, respectively, p = 0.022). Also, statistically significant differences were observed when comparing the genotype (G/G, G/A, A/A) distribution in the non-invasive PA group and the invasive PA group (3.4, 25.9, 70.7% vs. 0, 8.3, 91.7%, respectively, p = 0.003), and allele G was less frequently observed in invasive PA, than in non-invasive PA (4.2% vs. 16.4%, p
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 1471-2350
العلاقة: http://link.springer.com/article/10.1186/s12881-019-0892-xTest; https://doaj.org/toc/1471-2350Test
DOI: 10.1186/s12881-019-0892-x
الوصول الحر: https://doaj.org/article/66072ec7b4d64d868bc6a42b84031873Test
رقم الانضمام: edsdoj.66072ec7b4d64d868bc6a42b84031873
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:14712350
DOI:10.1186/s12881-019-0892-x